Gestational Hypertension

Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of new hypertension in a pregnant woman after 20 weeks’ gestation without the presence of protein in the urine or other signs of preeclampsia and eclampsia. Gestational hypertension is usually defined as having a blood pressure higher than 140/90 measured on two separate occasions, more than 6 hours apart, without the presence of protein in the urine and diagnosed after 20 weeks of gestation. There is no specific treatment, but is monitored closely to rapidly identify pre-eclampsia and its life-threatening complications.

Drug treatment options are limited, as many antihypertensive may negatively affect the fetus. Methyldopa, hydralazine, and labetalol are most commonly used for severe pregnancy hypertension. The fetus is at increased risk for a variety of life-threatening conditions, including pulmonary hypoplasia (immature lungs). If the dangerous complications appear after the fetus has reached a point of viability, even though still immature, then an early delivery may be warranted to save the lives of both mother and baby. An appropriate plan for labor and delivery includes selection of a hospital with provisions for advanced life support of newborn babies.

During gestational hypertension, a woman must be offered an integrated package of care, covering admission to hospital, treatment, measurement of blood pressure, testing for proteinuria and blood tests.

Gestational hypertension in a future pregnancy ranges from about 1 in 8 (13%) pregnancies to about 1 in 2 (53%) pregnancies.

  • Risk factors for gestational hypertension
  • Pre-eclampsia and eclampsia
  • Pathogenesis of pre-eclampsia
  • Genetic changes and stress incontinence.
  • Surgical and non-surgical conditions
  • Restorative and administration of medications
  • Drug treatment of gestational hypertension

Related Conference of Gestational Hypertension

November 02-03, 2017

3rd Global Summit on Heart Diseases

Bangkok, Thailand
December 11-12, 2017

22nd World Cardiology Conference

Rome, Italy
February 19-21, 2018

23rd European Heart Disease and Heart Failure Congress

Paris, France
19-20 March ,2018

23rd World Cardiology Conference

Hong Kong
April 19-20, 2018

3rd World Heart Congress

Amsterdam, Netherlands
May 14-16, 2018

2nd World Heart Congress

Tokyo, Japan
June 11-13, 2018

24th Annual Cardiologists Conference

Barcelona, Spain
July 11-12, 2018

International Conference on Cardiovascular Imaging

Sydney,Australia
July 18-19, 2018

25th Annual Cardiology Conference

Atlanta, USA
September 10-12, 2018

4th International Conference on Hypertension & Healthcare

Zurich, Switzerland
September 17-19,2018

25th Annual Cardiologists Conference

Tin Shui Wai,Hong Kong
October 17-18, 2018

Global Cardiology Summit

Seoul, South Korea

Gestational Hypertension Conference Speakers

Recommended Sessions

Related Journals

Are you interested in